您的位置: 首页 > 农业专利 > 详情页

DÉRIVÉ DE SULFONAMIDE OU SEL D'ADDITION D'ACIDE PHARMACEUTIQUEMENT ACCEPTABLE
专利权人:
University of Tsukuba;Board of Regents, The University of Texas System
发明人:
申请号:
EP18888690.7
公开号:
EP3725780A1
申请日:
2018.12.11
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention aims to provide a novel low-molecular-weight compound showing an orexin receptor agonist activity and expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the like. The present invention provides a compound represented by the formula (I):wherein each symbol is as described in the description, or a pharmaceutically acceptable acid addition salt thereof, which has an orexin receptor agonist activity, and an orexin receptor agonist containing the compound or a pharmaceutically acceptable acid addition salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充